Difference between revisions of "Brain metastasis"

From Libre Pathology
Jump to navigation Jump to search
(BM)
(→‎General: Treatment)
 
Line 41: Line 41:
*Percentage of previously diagnosed cancers with brain metastases - by primary site: lung cancer 19.9%, melanoma 6.9%, breast cancer 5.1%, renal cancer 6.5%, colorectal cancer 1.8%.<ref name=pmid15254054>{{Cite journal  | last1 = Barnholtz-Sloan | first1 = JS. | last2 = Sloan | first2 = AE. | last3 = Davis | first3 = FG. | last4 = Vigneau | first4 = FD. | last5 = Lai | first5 = P. | last6 = Sawaya | first6 = RE. | title = Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. | journal = J Clin Oncol | volume = 22 | issue = 14 | pages = 2865-72 | month = Jul | year = 2004 | doi = 10.1200/JCO.2004.12.149 | PMID = 15254054 }}</ref>
*Percentage of previously diagnosed cancers with brain metastases - by primary site: lung cancer 19.9%, melanoma 6.9%, breast cancer 5.1%, renal cancer 6.5%, colorectal cancer 1.8%.<ref name=pmid15254054>{{Cite journal  | last1 = Barnholtz-Sloan | first1 = JS. | last2 = Sloan | first2 = AE. | last3 = Davis | first3 = FG. | last4 = Vigneau | first4 = FD. | last5 = Lai | first5 = P. | last6 = Sawaya | first6 = RE. | title = Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. | journal = J Clin Oncol | volume = 22 | issue = 14 | pages = 2865-72 | month = Jul | year = 2004 | doi = 10.1200/JCO.2004.12.149 | PMID = 15254054 }}</ref>
**''Lung'' followed by ''kidney'' is the order in a smaller series.<ref>{{Cite journal  | last1 = Schouten | first1 = LJ. | last2 = Rutten | first2 = J. | last3 = Huveneers | first3 = HA. | last4 = Twijnstra | first4 = A. | title = Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma. | journal = Cancer | volume = 94 | issue = 10 | pages = 2698-705 | month = May | year = 2002 | doi =  | PMID = 12173339 }}</ref>
**''Lung'' followed by ''kidney'' is the order in a smaller series.<ref>{{Cite journal  | last1 = Schouten | first1 = LJ. | last2 = Rutten | first2 = J. | last3 = Huveneers | first3 = HA. | last4 = Twijnstra | first4 = A. | title = Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma. | journal = Cancer | volume = 94 | issue = 10 | pages = 2698-705 | month = May | year = 2002 | doi =  | PMID = 12173339 }}</ref>
*Treatment: Surgery 1-3 metastases, Stereotactic RT in 1-4(rarely up to 10) metastases, >4-10 metastases: Whole Brain RT.


==Gross/Radiology==
==Gross/Radiology==

Latest revision as of 11:04, 26 April 2024

Brain metastasis
Diagnosis in short

Metastatic adenocarcinoma, compatible with colorectal primary. HPS stain.
LM usu. well-demarcated border between brain and lesion, no cytoplasmic processes (seen in glial tumours), usu. have nuclear atypia of malignancy, +/-glandular architecture, +/-nucleoli seen
LM DDx primary brain tumour - see primary brain tumour versus secondary brain tumour
IHC GFAP -ve, dependent on primary - typical +ve for keratins (as carcinoma)
Site brain
Prevalence most common brain tumour (adults)
Radiology intra-axial, typically grey-white junction, cerebellum (esp. in adults)
Prognosis poor
Clin. DDx primary brain tumour, cerebral abscess or infection
Treatment surgery, chemotherapy, radiation therapy

Brain metastasis, also metastatic brain tumour,[1] is a brain tumour that arose elsewhere and spread to the brain.

General

  • Most common brain tumour in adults.[2][3]
    • Brain metastases are found in up to 25% cancer patients at autopsy. [4]
    • Incidence of brain metastases increases with age.
    • 80% of brain metastases are located supratentorial, usu. at the border between white and grey matter.
  • In more than 50% there are multiple metastases in the brain.
  • Common primary sites (in order of prevalence): lung, breast, kidney, gastrointestinal, melanoma.[5]
  • Percentage of previously diagnosed cancers with brain metastases - by primary site: lung cancer 19.9%, melanoma 6.9%, breast cancer 5.1%, renal cancer 6.5%, colorectal cancer 1.8%.[6]
    • Lung followed by kidney is the order in a smaller series.[7]
  • Treatment: Surgery 1-3 metastases, Stereotactic RT in 1-4(rarely up to 10) metastases, >4-10 metastases: Whole Brain RT.

Gross/Radiology

  • Intra-axial location.
    • Typically at the grey-white junction.[8]

Image:

  • Well demarcated metastasis (WC/Dr. Kostich)

  • 3 brain metastases in breast cancer (WC/Jmarchn)

Microscopic

Appearance varies by subtype.

Features of metastatic carcinoma:

  • Tubule formation/glands.
  • Usually well-circumscribed/sharply demarcated from surrounding tissue.
  • Usually nuclear atypia including:
    • Nuclear hyperchromasia.
    • Variation of nuclear size.
    • Variation of nuclear shape.
  • Mitoses - common.

DDx:

Images

  • CRC metastasis to cerebellum - very low mag. (WC)

  • CRC metastasis to the cerebellum - intermed. mag. (WC)

  • CRC metastasis to cerebellum - high mag. (WC)

  • Brain metastasis - high mag. (WC)

  • Adenocarcinoma of the lung metastasis. (WC/jensflorian)

IHC

Main article: Immunohistochemistry
  • Carcinoma: pankeratin +ve.
    • Lung adenocarcinoma and SCLC: TTF-1 +ve, CK7 +ve, CK20 -ve.
    • Breast carcinoma: CK7 +ve, ER +ve, PR +ve, BRST2 +ve/-ve.
    • Colorectal carcinoma: CK7 -ve, CK20 +ve, CDX2 +ve, TTF-1 -ve.
    • Clear cell renal cell carcinoma: PAX8 +ve, CK7 -ve, CK20 -ve, vimentin +ve, CD10 +ve.
  • Melanoma: S-100 +ve, HMB-45 +ve, Melan A +ve.
  • GFAP -ve.[9]

Other glial markers (suggest primary):[9]

  • OLIG2, SOX2.

  • CK7+/CK20-/TTF1+ profile in pulmonary adenocarcinoma metastasis. (WC/Marvin101)

Origin

Breast

  • 8-30% BM.
  • Triple-negative cases have a poor prognosis.

See also

References

  1. ↑ URL: http://www.nlm.nih.gov/medlineplus/ency/article/000769.htm. Accessed on: November 8, 2014.
  2. ↑ Pekmezci, M.; Perry, A. (2013). "Neuropathology of brain metastases.". Surg Neurol Int 4 (Suppl 4): S245-55. doi:10.4103/2152-7806.111302. PMID 23717796.
  3. ↑ Suki, D.; Khoury Abdulla, R.; Ding, M.; Khatua, S.; Sawaya, R. (Oct 2014). "Brain metastases in patients diagnosed with a solid primary cancer during childhood: experience from a single referral cancer center.". J Neurosurg Pediatr 14 (4): 372-85. doi:10.3171/2014.7.PEDS13318. PMID 25127097.
  4. ↑ Gavrilovic, IT.; Posner, JB. (Oct 2005). "Brain metastases: epidemiology and pathophysiology.". J Neurooncol 75 (1): 5-14. doi:10.1007/s11060-004-8093-6. PMID 16215811.
  5. ↑ Greenwald, J.; Heng, M. (2007). Toronto Notes for Medical Students 2007 (2007 ed.). The Toronto Notes Inc. for Medical Students Inc.. pp. NS9. ISBN 978-0968592878.
  6. ↑ Barnholtz-Sloan, JS.; Sloan, AE.; Davis, FG.; Vigneau, FD.; Lai, P.; Sawaya, RE. (Jul 2004). "Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System.". J Clin Oncol 22 (14): 2865-72. doi:10.1200/JCO.2004.12.149. PMID 15254054.
  7. ↑ Schouten, LJ.; Rutten, J.; Huveneers, HA.; Twijnstra, A. (May 2002). "Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma.". Cancer 94 (10): 2698-705. PMID 12173339.
  8. ↑ Della Puppa, A.; Dal Pos, S.; Zovato, S.; Orvieto, E.; Ciccarino, P.; Manara, R.; Zustovich, F.; Berti, F. et al. (Mar 2010). "Solitary intra-ventricular brain metastasis from a breast carcinoma.". J Neurooncol 97 (1): 123-6. doi:10.1007/s11060-009-9988-z. PMID 19727563.
  9. ↑ 9.0 9.1 9.2 Pekmezci, M.; Perry, A. (2013). "Neuropathology of brain metastases.". Surg Neurol Int 4 (Suppl 4): S245-55. doi:10.4103/2152-7806.111302. PMID 23717796.
Retrieved from "https://librepathology.org/w/index.php?title=Brain_metastasis&oldid=52929"